Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 301 to 307 of 307 entries
Sorted by: Best Match Show Resources per page
Surgical management of deep pelvic endometriosis in France: Do we need to be a pelvic surgeon to deal with DPE?.

Journal of gynecology obstetrics and human reproduction

Pellerin M, Faller E, Minella C, Garbin O, Host A, Lecointre L, Akladios C.
PMID: 33945889
J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102158. doi: 10.1016/j.jogoh.2021.102158. Epub 2021 May 01.

INTRODUCTION: Endometriosis is a common disease in women, which requires a medical and surgical approach. Surgical societies recommend a multidisciplinary management in tertiary referral centers. The objective of our study is to assess the surgical management of endometriosis in...

Cite
Pellerin M, Faller E, Minella C, et al. Surgical management of deep pelvic endometriosis in France: Do we need to be a pelvic surgeon to deal with DPE?. J Gynecol Obstet Hum Reprod. 2021;50(9):102158doi: 10.1016/j.jogoh.2021.102158.
Pellerin, M., Faller, E., Minella, C., Garbin, O., Host, A., Lecointre, L., & Akladios, C. (2021). Surgical management of deep pelvic endometriosis in France: Do we need to be a pelvic surgeon to deal with DPE?. Journal of gynecology obstetrics and human reproduction, 50(9), 102158. https://doi.org/10.1016/j.jogoh.2021.102158
Pellerin, Madeleine, et al. "Surgical management of deep pelvic endometriosis in France: Do we need to be a pelvic surgeon to deal with DPE?." Journal of gynecology obstetrics and human reproduction vol. 50,9 (2021): 102158. doi: https://doi.org/10.1016/j.jogoh.2021.102158
Pellerin M, Faller E, Minella C, Garbin O, Host A, Lecointre L, Akladios C. Surgical management of deep pelvic endometriosis in France: Do we need to be a pelvic surgeon to deal with DPE?. J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102158. doi: 10.1016/j.jogoh.2021.102158. Epub 2021 May 01. PMID: 33945889.
Copy Download .nbib Format: NLM
MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response.

Brain : a journal of neurology

Pellerin K, Rubino SJ, Burns JC, Smith BA, McCarl CA, Zhu J, Jandreski L, Cullen P, Carlile TM, Li A, Rebollar JV, Sybulski J, Reynolds TL, Zhang B, Basile R, Tang H, Harp CP, Pellerin A, Silbereis J, Franchimont N, Cahir-McFarland E, Ransohoff RM, Cameron TO, Mingueneau M.
PMID: 34145876
Brain. 2021 Sep 04;144(8):2361-2374. doi: 10.1093/brain/awab231.

Autoantibodies are a hallmark of numerous neurological disorders, including multiple sclerosis, autoimmune encephalitides and neuromyelitis optica. Whilst well understood in peripheral myeloid cells, the pathophysiological significance of autoantibody-induced Fc receptor signalling in microglia remains unknown, in part due to...

Cite
Pellerin K, Rubino SJ, Burns JC, et al. MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Brain. 2021;144(8):2361-2374doi: 10.1093/brain/awab231.
Pellerin, K., Rubino, S. J., Burns, J. C., Smith, B. A., McCarl, C. A., Zhu, J., Jandreski, L., Cullen, P., Carlile, T. M., Li, A., Rebollar, J. V., Sybulski, J., Reynolds, T. L., Zhang, B., Basile, R., Tang, H., Harp, C. P., Pellerin, A., Silbereis, J., Franchimont, N., Cahir-McFarland, E., Ransohoff, R. M., Cameron, T. O., & Mingueneau, M. (2021). MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Brain : a journal of neurology, 144(8), 2361-2374. https://doi.org/10.1093/brain/awab231
Pellerin, Kathryn, et al. "MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response." Brain : a journal of neurology vol. 144,8 (2021): 2361-2374. doi: https://doi.org/10.1093/brain/awab231
Pellerin K, Rubino SJ, Burns JC, Smith BA, McCarl CA, Zhu J, Jandreski L, Cullen P, Carlile TM, Li A, Rebollar JV, Sybulski J, Reynolds TL, Zhang B, Basile R, Tang H, Harp CP, Pellerin A, Silbereis J, Franchimont N, Cahir-McFarland E, Ransohoff RM, Cameron TO, Mingueneau M. MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Brain. 2021 Sep 04;144(8):2361-2374. doi: 10.1093/brain/awab231. PMID: 34145876.
Copy Download .nbib Format: NLM
Focal hepatic lesions in acid sphingomyelinase deficiency: Differential diagnosis between foamy macrophages aggregates and malignancy.

Molecular genetics and metabolism reports

Sechi A, Vit A, Avellini C, Dardis A, Pellegrin A, Scarpa M, Bembi B.
PMID: 34660203
Mol Genet Metab Rep. 2021 Oct 05;29:100808. doi: 10.1016/j.ymgmr.2021.100808. eCollection 2021 Dec.

Acid sphingomyelinase deficiency (ASMD) is a rare metabolic disorder due to biallelic mutation in the SMPD1 gene. The defect leads to the accumulation of sphingomyelin within the cells of the reticulo-endothelial system, particularly in the spleen, liver, lungs, and...

Cite
Sechi A, Vit A, Avellini C, et al. Focal hepatic lesions in acid sphingomyelinase deficiency: Differential diagnosis between foamy macrophages aggregates and malignancy. Mol Genet Metab Rep. 2021;29:100808doi: 10.1016/j.ymgmr.2021.100808.
Sechi, A., Vit, A., Avellini, C., Dardis, A., Pellegrin, A., Scarpa, M., & Bembi, B. (2021). Focal hepatic lesions in acid sphingomyelinase deficiency: Differential diagnosis between foamy macrophages aggregates and malignancy. Molecular genetics and metabolism reports, 29100808. https://doi.org/10.1016/j.ymgmr.2021.100808
Sechi, Annalisa, et al. "Focal hepatic lesions in acid sphingomyelinase deficiency: Differential diagnosis between foamy macrophages aggregates and malignancy." Molecular genetics and metabolism reports vol. 29 (2021): 100808. doi: https://doi.org/10.1016/j.ymgmr.2021.100808
Sechi A, Vit A, Avellini C, Dardis A, Pellegrin A, Scarpa M, Bembi B. Focal hepatic lesions in acid sphingomyelinase deficiency: Differential diagnosis between foamy macrophages aggregates and malignancy. Mol Genet Metab Rep. 2021 Oct 05;29:100808. doi: 10.1016/j.ymgmr.2021.100808. eCollection 2021 Dec. PMID: 34660203; PMCID: PMC8502771.
Copy Download .nbib Format: NLM
Radiation Hardness of 4H-SiC P-N Junction UV Photo-Detector.

Materials (Basel, Switzerland)

Sciuto A, Calcagno L, Di Franco S, Pellegrino D, Selgi LM, D'Arrigo G.
PMID: 35009409
Materials (Basel). 2021 Dec 30;15(1). doi: 10.3390/ma15010264.

4H-SiC based p-n junction UV photo-detectors were irradiated with 600 keV He

Cite
Sciuto A, Calcagno L, Di Franco S, et al. Radiation Hardness of 4H-SiC P-N Junction UV Photo-Detector. Materials (Basel). 2021;15(1)doi: 10.3390/ma15010264.
Sciuto, A., Calcagno, L., Di Franco, S., Pellegrino, D., Selgi, L. M., & D'Arrigo, G. (2021). Radiation Hardness of 4H-SiC P-N Junction UV Photo-Detector. Materials (Basel, Switzerland), 15(1), . https://doi.org/10.3390/ma15010264
Sciuto, Antonella, et al. "Radiation Hardness of 4H-SiC P-N Junction UV Photo-Detector." Materials (Basel, Switzerland) vol. 15,1 (2021). doi: https://doi.org/10.3390/ma15010264
Sciuto A, Calcagno L, Di Franco S, Pellegrino D, Selgi LM, D'Arrigo G. Radiation Hardness of 4H-SiC P-N Junction UV Photo-Detector. Materials (Basel). 2021 Dec 30;15(1). doi: 10.3390/ma15010264. PMID: 35009409; PMCID: PMC8746246.
Copy Download .nbib Format: NLM
The COVID-19 pandemic and eating disorders in children, adolescents, and emerging adults: virtual care recommendations from the Canadian consensus panel during COVID-19 and beyond.

Journal of eating disorders

Couturier J, Pellegrini D, Miller C, Bhatnagar N, Boachie A, Bourret K, Brouwers M, Coelho JS, Dimitropoulos G, Findlay S, Ford C, Geller J, Grewal S, Gusella J, Isserlin L, Jericho M, Johnson N, Katzman DK, Kimber M, Lafrance A, Leclerc A, Loewen R, Loewen T, McVey G, Norris M, Pilon D, Preskow W, Spettigue W, Steinegger C, Waite E, Webb C.
PMID: 33863388
J Eat Disord. 2021 Apr 16;9(1):46. doi: 10.1186/s40337-021-00394-9.

OBJECTIVE: The COVID-19 pandemic has had detrimental effects on mental health. Literature on the impact on individuals with eating disorders is slowly emerging. While outpatient eating disorder services in Canada have attempted to transition to virtual care, guidelines related...

Cite
Couturier J, Pellegrini D, Miller C, et al. The COVID-19 pandemic and eating disorders in children, adolescents, and emerging adults: virtual care recommendations from the Canadian consensus panel during COVID-19 and beyond. J Eat Disord. 2021;9(1):46doi: 10.1186/s40337-021-00394-9.
Couturier, J., Pellegrini, D., Miller, C., Bhatnagar, N., Boachie, A., Bourret, K., Brouwers, M., Coelho, J. S., Dimitropoulos, G., Findlay, S., Ford, C., Geller, J., Grewal, S., Gusella, J., Isserlin, L., Jericho, M., Johnson, N., Katzman, D. K., Kimber, M., Lafrance, A., Leclerc, A., Loewen, R., Loewen, T., McVey, G., Norris, M., Pilon, D., Preskow, W., Spettigue, W., Steinegger, C., Waite, E., & Webb, C. (2021). The COVID-19 pandemic and eating disorders in children, adolescents, and emerging adults: virtual care recommendations from the Canadian consensus panel during COVID-19 and beyond. Journal of eating disorders, 9(1), 46. https://doi.org/10.1186/s40337-021-00394-9
Couturier, Jennifer, et al. "The COVID-19 pandemic and eating disorders in children, adolescents, and emerging adults: virtual care recommendations from the Canadian consensus panel during COVID-19 and beyond." Journal of eating disorders vol. 9,1 (2021): 46. doi: https://doi.org/10.1186/s40337-021-00394-9
Couturier J, Pellegrini D, Miller C, Bhatnagar N, Boachie A, Bourret K, Brouwers M, Coelho JS, Dimitropoulos G, Findlay S, Ford C, Geller J, Grewal S, Gusella J, Isserlin L, Jericho M, Johnson N, Katzman DK, Kimber M, Lafrance A, Leclerc A, Loewen R, Loewen T, McVey G, Norris M, Pilon D, Preskow W, Spettigue W, Steinegger C, Waite E, Webb C. The COVID-19 pandemic and eating disorders in children, adolescents, and emerging adults: virtual care recommendations from the Canadian consensus panel during COVID-19 and beyond. J Eat Disord. 2021 Apr 16;9(1):46. doi: 10.1186/s40337-021-00394-9. PMID: 33863388; PMCID: PMC8050997.
Copy Download .nbib Format: NLM
Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.

Thrombosis research

Bolzacchini E, Pomero F, Fazio M, Civitelli C, Fabro G, Pellegrino D, Giordano M, Squizzato A.
PMID: 34814055
Thromb Res. 2021 Dec;208:190-197. doi: 10.1016/j.thromres.2021.11.009. Epub 2021 Nov 17.

BACKGROUND: Cyclin-dependent kinase inhibitors (CDKIs) may increase the risk of thrombotic events of endocrine therapy (ET) in women with hormone-sensitive, HER2-negative advanced breast cancer (BC). Aim of our systematic review is the estimate of the risk of venous and...

Cite
Bolzacchini E, Pomero F, Fazio M, et al. Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis. Thromb Res. 2021;208:190-197doi: 10.1016/j.thromres.2021.11.009.
Bolzacchini, E., Pomero, F., Fazio, M., Civitelli, C., Fabro, G., Pellegrino, D., Giordano, M., & Squizzato, A. (2021). Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis. Thrombosis research, 208190-197. https://doi.org/10.1016/j.thromres.2021.11.009
Bolzacchini, Elena, et al. "Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis." Thrombosis research vol. 208 (2021): 190-197. doi: https://doi.org/10.1016/j.thromres.2021.11.009
Bolzacchini E, Pomero F, Fazio M, Civitelli C, Fabro G, Pellegrino D, Giordano M, Squizzato A. Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis. Thromb Res. 2021 Dec;208:190-197. doi: 10.1016/j.thromres.2021.11.009. Epub 2021 Nov 17. PMID: 34814055.
Copy Download .nbib Format: NLM
Systemic administration of sunflower oil exerts neuroprotection in a mouse model of transient focal cerebral ischaemia.

The Journal of pharmacy and pharmacology

La Russa D, Montesano D, Pellegrino D, Frisina M, Bagetta G, Fallarino F, Amantea D.
PMID: 33749789
J Pharm Pharmacol. 2021 Mar 22; doi: 10.1093/jpp/rgab007. Epub 2021 Mar 22.

OBJECTIVES: Natural products are valuable sources of nutraceuticals for the prevention or treatment of ischemic stroke, a major cause of death and severe disability worldwide. Among the mechanisms implicated in cerebral ischemia-reperfusion damage, oxidative stress exerts a pivotal role...

Cite
La Russa D, Montesano D, Pellegrino D, et al. Systemic administration of sunflower oil exerts neuroprotection in a mouse model of transient focal cerebral ischaemia. J Pharm Pharmacol. 2021;doi: 10.1093/jpp/rgab007.
La Russa, D., Montesano, D., Pellegrino, D., Frisina, M., Bagetta, G., Fallarino, F., & Amantea, D. (2021). Systemic administration of sunflower oil exerts neuroprotection in a mouse model of transient focal cerebral ischaemia. The Journal of pharmacy and pharmacology, . https://doi.org/10.1093/jpp/rgab007
La Russa, Daniele, et al. "Systemic administration of sunflower oil exerts neuroprotection in a mouse model of transient focal cerebral ischaemia." The Journal of pharmacy and pharmacology vol. (2021). doi: https://doi.org/10.1093/jpp/rgab007
La Russa D, Montesano D, Pellegrino D, Frisina M, Bagetta G, Fallarino F, Amantea D. Systemic administration of sunflower oil exerts neuroprotection in a mouse model of transient focal cerebral ischaemia. J Pharm Pharmacol. 2021 Mar 22; doi: 10.1093/jpp/rgab007. Epub 2021 Mar 22. PMID: 33749789.
Copy Download .nbib Format: NLM
Showing 301 to 307 of 307 entries